BMJ  2005;330:373-374 (19 February), doi:10.1136/bmj.330.7488.373

Editorial

Suicide, depression, and antidepressants

Patients and clinicians need to balance benefits and harms

The first 150 words of the full text of this article appear below.

Unipolar depression, one of the most important causes of disability worldwide,1 is characterised by depressed mood, hopelessness, helplessness, intense feelings of guilt, sadness, low self esteem, thoughts of self harm, and suicide. Up to 15% of patients with unipolar depression eventually commit suicide.2 Although clinical guidelines recommend treating moderate to severe depression with antidepressant drugs,3 debate persists on whether some antidepressant drugs, in particular the selective serotonin reuptake inhibitors (SSRIs), cause the emergence or worsening of suicidal ideas in vulnerable patients. New insights on this key issue have been provided by three articles published in this issue.

Fergusson et al conducted a systematic review of published randomised controlled trials comparing SSRIs with either placebo or other active treatments in patients with depression and other clinical conditions.4 They found an almost twofold increase in the odds of fatal and non-fatal suicidal attempts in users of SSRIs compared with users of . . . [Full text of this article]

Andrea Cipriani, research fellow in psychiatry

Department of Medicine and Public Health, Section of Psychiatry and Clinical Psychology, University of Verona, 37134 Verona, Italy (andrea.cipriani@medicina.univr.it)

Corrado Barbui, lecturer in psychiatry

Department of Medicine and Public Health, Section of Psychiatry and Clinical Psychology, University of Verona, 37134 Verona, Italy

John R Geddes, professor of epidemiological psychiatry

Department of Psychiatry, University of Oxford, Warneford Hospital, Oxford OX3 7JX


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Related Articles

Drug safety and regulation
Patrick C Waller, Stephen J W Evans, and Keith Beard
BMJ 2005 331: 4-5. [Extract] [Full Text] [PDF]

Do selective serotonin reuptake inhibitors cause suicide?: Let's keep it in perspective
Isaac Sakinofsky and David L Streiner
BMJ 2005 330: 1149. [Extract] [Full Text]

Do selective serotonin reuptake inhibitors cause suicide?: Data seem to be incorrect
Alex J Mitchell
BMJ 2005 330: 1149-1150. [Extract] [Full Text]

Do selective serotonin reuptake inhibitors cause suicide?: Suicide rate of 15% in editorial is misleading
Melissa K Raven
BMJ 2005 330: 1150. [Extract] [Full Text]

Do selective serotonin reuptake inhibitors cause suicide?: Antidepressant prescribing to children and adolescents by GPs has fallen since CSM advice
Macey L Murray, Ian C K Wong, and Mary Thompson
BMJ 2005 330: 1151. [Extract] [Full Text]

SSRIs and suicide: risks seem to be similar to risks with tricyclics
BMJ 2005 330: 0. [Full Text]

Pills, thrills, and bellyaches
Kamran Abbasi
BMJ 2005 330: 0. [Extract] [Full Text] [PDF]

Selective serotonin reuptake inhibitors (SSRIs) and suicide in adults: meta-analysis of drug company data from placebo controlled, randomised controlled trials submitted to the MHRA's safety review
David Gunnell, Julia Saperia, and Deborah Ashby
BMJ 2005 330: 385. [Abstract] [Full Text] [PDF]

Antidepressant treatment and the risk of fatal and non-fatal self harm in first episode depression: nested case-control study
Carlos Martinez, Stephan Rietbrock, Lesley Wise, Deborah Ashby, Jonathan Chick, Jane Moseley, Stephen Evans, and David Gunnell
BMJ 2005 330: 389. [Abstract] [Full Text] [PDF]

Association between suicide attempts and selective serotonin reuptake inhibitors: systematic review of randomised controlled trials
Dean Fergusson, Steve Doucette, Kathleen Cranley Glass, Stan Shapiro, David Healy, Paul Hebert, and Brian Hutton
BMJ 2005 330: 396. [Abstract] [Full Text] [PDF]

This article has been cited by other articles:

  • Barbui, C., Cipriani, A., Geddes, J. R (2008). Antidepressants and suicide symptoms: compelling new insights from the FDA's analysis of individual patient level data. Evid. Based Ment. Health 11: 34-35 [Full text]  
  • Tint, A., Haddad, P. M, Anderson, I. M (2008). The effect of rate of antidepressant tapering on the incidence of discontinuation symptoms: a randomised study. J Psychopharmacol 22: 330-332 [Abstract]  
  • Barbui, C. MD, Furukawa, T. A. MD, Cipriani, A. MD (2008). Effectiveness of paroxetine in the treatment of acute major depression in adults: a systematic re-examination of published and unpublished data from randomized trials. CMAJ 178: 296-305 [Abstract] [Full text]  
  • Cipriani, A., Geddes, J. R, Barbui, C. (2007). Venlafaxine for major depression. BMJ 334: 215-216 [Full text]  
  • Olfson, M., Marcus, S. C., Shaffer, D. (2006). Antidepressant drug therapy and suicide in severely depressed children and adults: a case-control study.. Arch Gen Psychiatry 63: 865-872 [Abstract] [Full text]  
  • McHenry, L (2006). Ethical issues in psychopharmacology.. J. Med. Ethics 32: 405-410 [Abstract] [Full text]  
  • Uebelhack, R., Blohmer, J.-U., Graubaum, H.-J., Busch, R., Gruenwald, J., Wernecke, K.-D. (2006). Black Cohosh and St. John's Wort for Climacteric Complaints: A Randomized Trial. Obstet Gynecol 107: 247-255 [Abstract] [Full text]  
  • Cipriani, A. (2005). Forensic database study suggests selective serotonin reuptake inhibitors do not increase the risk of suicide in people taking antidepressants. Evid. Based Ment. Health 8: 113-113 [Full text]  
  • Waller, P. C, Evans, S. J W, Beard, K. (2005). Drug safety and regulation. BMJ 331: 4-5 [Full text]  
  • Murray, M. L, Wong, I. C K, Thompson, M. (2005). Do selective serotonin reuptake inhibitors cause suicide?: Antidepressant prescribing to children and adolescents by GPs has fallen since CSM advice. BMJ 330: 1151-1151 [Full text]  
  • Sakinofsky, I., Streiner, D. L (2005). Do selective serotonin reuptake inhibitors cause suicide?: Let's keep it in perspective. BMJ 330: 1149-1149 [Full text]  
  • Mitchell, A. J (2005). Do selective serotonin reuptake inhibitors cause suicide?: Data seem to be incorrect. BMJ 330: 1149-1150 [Full text]  
  • Raven, M. K (2005). Do selective serotonin reuptake inhibitors cause suicide?: Suicide rate of 15% in editorial is misleading. BMJ 330: 1150-1150 [Full text]  
  • (2005). Do SSRIs Increase Suicide Risk in Adults?. Journal Watch Dermatology 2005: 10-10 [Full text]  
  • (2005). Do SSRIs Increase Suicide Risk in Adults?. JWatch General 2005: 6-6 [Full text]  
  • (2005). SSRIs and Suicide Risk: A Concern for Adults, Too?. JWatch Psychiatry 2005: 1-1 [Full text]  

Rapid Responses:

Read all Rapid Responses

Misleading statement re 15% suicide
Melissa K Raven
bmj.com, 18 Feb 2005 [Full text]
Decline in antidepressant prescribing to children and adolescents in primary care since UK CSM advice
Macey L Murray, et al.
bmj.com, 18 Feb 2005 [Full text]
Suicide, depression & antidepressants
Peter O'Loughlin
bmj.com, 19 Feb 2005 [Full text]
15%! The figures don't add up.
Andrew J Smith
bmj.com, 19 Feb 2005 [Full text]
Antidepressants and Increased Risk of Suicide
Peter J T Balfour
bmj.com, 22 Feb 2005 [Full text]
No indication for increased rate of suicide attempts by SSRIs in the Netherlands
Richard L Marquet, et al.
bmj.com, 3 Mar 2005 [Full text]
Suicide attempts on drug medications
Ellen C G Grant
bmj.com, 4 Mar 2005 [Full text]
Re: No indication for increased rate of suicide attempts by SSRIs in the Netherlands
John P Heptonstall
bmj.com, 4 Mar 2005 [Full text]
Selective Serotonin Reuptake Inhibitors (SSRIs) and Suicide Fatalities
Raymond Crowe
bmj.com, 24 Mar 2005 [Full text]



Student BMJ

Intimate examinations

Israeli students are refusing to perform intimate examinations on anaesthetised women without their informed consent.

www.student.bmj.com

Listen to the latest BMJ Interview